Hilario R, Padre-Mendoza T, Albala M M
Am J Med Sci. 1980 Sep-Oct;280(2):115-8. doi: 10.1097/00000441-198009000-00008.
A 26-year-old white female presented with Philadelphia chromosome positive chronic granulocytic leukemia five years after successful renal transplantation and prolonged therapy with azathioprine and prednisone. This patient represents the seventh case of the chronic granulocytic leukemia reported within the population of immunosuppressed renal transplant recipients. Of further interest in our case is the development of carcinoma in situ of the cervix two years following the transplant. Although multiple malignancies have been recognized in renal homografts, the occurrence of chronic granulocytic leukemia and carcinoma in situ in the same patient has not been previously described. A possible mechanism for the development of chronic granulocytic leukemia is the association of chromosome damage by azathioprine and immunoparalysis of the host, thus setting the stage for the emergency of a malignant clone. The importance of close follow-up of patients on prolonged immunosuppressive therapy is emphasized.
一名26岁的白人女性在肾移植成功并接受硫唑嘌呤和泼尼松长期治疗五年后,出现了费城染色体阳性的慢性粒细胞白血病。该患者是免疫抑制的肾移植受者群体中报告的第七例慢性粒细胞白血病病例。在我们的病例中,更值得关注的是移植两年后宫颈原位癌的发生。虽然在同种肾移植中已认识到多种恶性肿瘤,但同一患者同时发生慢性粒细胞白血病和原位癌此前尚未见报道。慢性粒细胞白血病发生的一种可能机制是硫唑嘌呤引起的染色体损伤与宿主免疫麻痹相关联,从而为恶性克隆的出现奠定了基础。强调了对长期接受免疫抑制治疗的患者进行密切随访的重要性。